BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 33690729)

  • 1. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
    Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
    PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
    Zhang Q; Celestino J; Schmandt R; McCampbell AS; Urbauer DL; Meyer LA; Burzawa JK; Huang M; Yates MS; Iglesias D; Broaddus RR; Lu KH
    Am J Obstet Gynecol; 2013 Jul; 209(1):24.e1-24.e12. PubMed ID: 23500454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
    Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
    Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
    Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
    Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells.
    Lange C; Brüggemann J; Thüner T; Jauckus J; Strowitzki T; Germeyer A
    Heliyon; 2023 Jun; 9(6):e16678. PubMed ID: 37313172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
    Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
    Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.
    Sivalingam VN; Myers J; Nicholas S; Balen AH; Crosbie EJ
    Hum Reprod Update; 2014; 20(6):853-68. PubMed ID: 25013215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
    Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
    PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of metformin on the estrogen-induced proliferation and the expression of ER in human endometrial cancer cells].
    Zhang J; Zhang B; Yin Z; Chen F; Liu T; Xu H; Liu Y; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):932-7. PubMed ID: 25608995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
    Liu Y; Wang Y; Yao D; Chen X; Zhang F; Feng Y; Li X
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin.
    Ferreira GD; Germeyer A; de Barros Machado A; do Nascimento TL; Strowitzki T; Brum IS; von Eye Corleta H; Capp E
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():157-62. PubMed ID: 24480115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of metformin and adiponectin on endometrial cancer cells growth].
    Wang XH; Zhang Y; Liu LZ; Shang CG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):767-773. PubMed ID: 30337733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
    Sivalingam VN; Kitson S; McVey R; Roberts C; Pemberton P; Gilmour K; Ali S; Renehan AG; Kitchener HC; Crosbie EJ
    Br J Cancer; 2016 Feb; 114(3):281-9. PubMed ID: 26794276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
    Soliman PT; Zhang Q; Broaddus RR; Westin SN; Iglesias D; Munsell MF; Schmandt R; Yates M; Ramondetta L; Lu KH
    Gynecol Oncol; 2016 Dec; 143(3):466-471. PubMed ID: 27745917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
    Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
    Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.